Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that data from the ongoing Phase 1b study of R2891, a potent and ...
The rise of infections caused by Mgen, C. auris, treatment-resistant E. coli, and more could become future public-health ...
While some researchers note the models made tasks more efficient, many scientists remain skeptical about using A.I. to author ...
GYEONGJU, North Gyeongsang Province — Google Asia-Pacific Chief Marketing Officer Simon Kahn urged global leaders to adopt a ...
Ozempic, MRI machines and flat screen televisions all emerged out of fundamental research decades earlier — the very types of ...
Nigel Langley of gChem discusses the company’s DMSO, proactive pharma strategies, and more in part 1 of a 2-part interview ...
- Food and Drug Administration grants rolling review of Biologics License Application for povetacicept in IgA nephropathy; Vertex (VRTX) to submit first module before end of year - - Second pivotal ...
CHICAGO, October 15, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced that six abstracts have been ...
ROCKVILLE, Md. & EDMONTON, Alberta — Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) today announced that five posters will be presented in collaboration with independent investigators highlighting new ...
BAY CITY, MI – The Saginaw River Marine Historical Society will present a free program featuring drone photography and insights into the future of the Saginaw River on Saturday, Oct. 18. Gordy Garris, ...
Since homo sapiens first emerged, humanity has enjoyed an unbeaten 300,000–year run as the most intelligent creatures on the planet. However, thanks to rapid advances in artificial intelligence (AI), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback